UCHL1 and COVID-19: Our transcriptional analysis suggests that the elevated serum UCHL1 protein levels could be a hallmark of severe illness in acute COVID-19 patients; theoretically, this protein might be involved in opportunistic direct attack on the brain or systemic secondary insult including thrombosis, hypoxemia, or autoimmune response.